CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 90 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.06 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,074,681 | +1.5% | 111,542 | -30.0% | 0.54% | -1.3% |
| Q3 2022 | $2,044,000 | +18.6% | 159,290 | -35.2% | 0.54% | +28.4% |
| Q2 2022 | $1,724,000 | -29.0% | 245,976 | -16.0% | 0.42% | -5.6% |
| Q1 2022 | $2,427,000 | +3.1% | 292,765 | -15.8% | 0.45% | +7.2% |
| Q4 2021 | $2,355,000 | +67.1% | 347,899 | +25.9% | 0.42% | -33.0% |
| Q1 2019 | $1,409,000 | +43.2% | 276,228 | +9.8% | 0.62% | +23.8% |
| Q4 2017 | $984,000 | – | 251,647 | – | 0.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 589,883 | $590,000 | 1.38% |
| Broadfin Capital, LLC | 8,200,000 | $8,610,000 | 0.96% |
| Avoro Capital Advisors LLC | 1,141,149 | $1,198,000 | 0.24% |
| CORRADO ADVISORS, LLC | 190,600 | $200,000 | 0.12% |
| Baker Brothers Advisors | 5,102,153 | $5,357,000 | 0.05% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 756,311 | $794,000 | 0.04% |
| Point72 Asset Management, L.P. | 2,272,816 | $2,386,000 | 0.02% |
| AGRAN LIBBIE | 44,000 | $46,000 | 0.01% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 10,000 | $11,000 | 0.01% |
| KENNEDY CAPITAL MANAGEMENT LLC | 233,171 | $245,000 | 0.00% |